At Thermo Fisher Scientific, I managed labeling projects and supported IVDR work, including ECO approvals and releases. I prepared specifications for labeling changes, updated documentation for Product Change Orders, and worked with cross-functional teams on compliant product labeling.
Previously, I processed and reviewed clinical and post-marketing safety cases at Halozyme Therapeutics, Inc., Janssen Pharmaceuticals (J&J), Bristol Myers Squibb (BMS), Syneos, and Taro Pharmaceuticals. My work included adverse event assessment, MedDRA coding, case narratives, regulatory reporting, and safety database processing using Argus and ARISg.

